Tuberculosis News and Research

Latest Tuberculosis News and Research

Study reveals neglected or late TB diagnoses related to COVID-19

In a recent study published in the journal BMJ Medicine, researchers modeled changing patterns in sex- and age-stratified new and relapse tuberculosis (TB) case notifications reported to the World Health Organization (WHO) for 45 nations with high TB, TB/human immunodeficiency virus (HIV) and multidrug-resistant TB (MDR-TB) burden between 2013 and 2019 due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

16 Nov 2022

Novel nasal vaccine approach induces potent lung immunity and protection against SARS-CoV-2

Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.

16 Nov 2022

Certain TB correlates of protection linked with the likelihood of becoming infected with Mycobacterium tuberculosis

Researchers from the University of Oxford have today reported findings from a study that investigated whether previously identified correlates of protection associated with risk of full-blown tuberculosis (TB) disease could also be associated with risk of infection from the bacteria that causes TB.

15 Nov 2022

Oral deucravacitinib shows promise in patients with active lupus

Tyrosine kinases are enzymes that play central roles in signaling by cytokines involved in the pathogenesis of autoimmune diseases, including lupus.

14 Nov 2022

New UK aid will help fight AIDS, tuberculosis, and malaria

New UK aid support to the Global Fund will help fight AIDS, tuberculosis, and malaria around the world, Minister for Development Andrew Mitchell announced today (Monday 14 November).

14 Nov 2022

How lessons from the HIV epidemic can help combat COVID-19

Researchers revisit lessons learned from the HIV pandemic in response to COVID-19.

13 Nov 2022

Proteomics approach helps identify protein signatures that can improve detection of prediabetes

Scientists have used a proteomics approach to identify a three-protein signature in the blood that can improve detection of isolated impaired glucose tolerance, a form of prediabetes.

10 Nov 2022

Irish Government funds tripartite collaboration to explore the role of vitamin D in bovine TB

The Irish Government has funded a tripartite collaboration to investigate the role of vitamin D in bovine tuberculosis (bTB).

10 Nov 2022

Pioneering artificial intelligence could ease winter pressures on hospitals

Pioneering artificial intelligence (AI) which automatically diagnoses lung diseases – such as tuberculosis and pneumonia – could ease winter pressures on hospitals, University of the West of Scotland researchers believe.

7 Nov 2022

Post-‘Roe,’ contraceptive failures carry bigger stakes

Birth control options have improved over the decades. Oral contraceptives are now safer, with fewer side effects. Intrauterine devices can prevent pregnancy 99.6% of the time. But no prescription drug or medical device works flawlessly, and people's use of contraception is inexact.

7 Nov 2022

New test detects low levels of pathogenic amphiphilic endotoxins

Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a fast and cost-effective method to test liquids for a ubiquitous family of chemical compounds known as amphiphiles, which are used to detect diseases such as early-stage tuberculosis and cancer as well as to detect toxins in drugs, food, medical devices and water supplies.

3 Nov 2022

New insights into the dynamic inner world of the human immune system

As researchers glean new insights into the dynamic inner world of the human immune system, it has become increasingly clear that mitochondria are critical regulators of how our bodies respond to disease.

3 Nov 2022

COVID-19 pandemic increased deaths and disease caused by tuberculosis

A new report published by the World Health Organization indicated a decrease in global spending on essential TB services from US$6 billion in 2019 to US$5.4 billion in 2021.

31 Oct 2022

An unprecedented list of health-threatening fungi released by the WHO

The WHO fungal priority pathogens list ranks pathogens that pose a serious risk of morbidity and mortality in humans.

27 Oct 2022

Harmless group of bacteria linked with increased risk of death in patients with end-stage renal disease

A big group of bacteria found in our soil, our water and our showerheads are harmless for most of us, but a new study indicates they are associated with an increased risk of dying in individuals whose kidneys have failed.

25 Oct 2022

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Researchers explored the impact of the coronavirus disease 2019 (COVID-19) pandemic-associated non-pharmaceutical prevention measures on the transmission of 22 infectious diseases in England.

25 Oct 2022

The Black Death may have influenced the evolution of genes involved in immune responses against pathogens

Researchers gathered empirical evidence that past pandemics due to infectious pathogens shaped the present-day susceptibility of humans to diseases, such as autoimmune diseases.

24 Oct 2022

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

The AIDS Clinical Trials Group (ACTG), the world's largest HIV research network whose focus has expanded to include evaluating outpatient treatment for COVID-19, today presented a session demonstrating that a three-dose regimen of the HEPLISAV-B vaccine fully protected people living with HIV at IDWeek 2022, taking place in Washington D.C. from October 19-22, 2022.

20 Oct 2022

Researchers receive £9.8m to tackle the rising challenge of non-communicable diseases in West Africa

Researchers from the London School of Hygiene & Tropical Medicine are teaming up with the Ghana College of Physicians and Surgeons to tackle the rising challenge of non-communicable diseases (NCDs) in West Africa.

14 Oct 2022

Chinese scientists reveal a previously undefined pathway by which Mtb counteracts host immunity

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), remains a leading infectious threat to public health worldwide.

13 Oct 2022

Tuberculosis News and Research

Latest Tuberculosis News and Research

Study reveals neglected or late TB diagnoses related to COVID-19

Novel nasal vaccine approach induces potent lung immunity and protection against SARS-CoV-2

Certain TB correlates of protection linked with the likelihood of becoming infected with Mycobacterium tuberculosis

Oral deucravacitinib shows promise in patients with active lupus

New UK aid will help fight AIDS, tuberculosis, and malaria

How lessons from the HIV epidemic can help combat COVID-19

Proteomics approach helps identify protein signatures that can improve detection of prediabetes

Irish Government funds tripartite collaboration to explore the role of vitamin D in bovine TB

Pioneering artificial intelligence could ease winter pressures on hospitals

Post-‘Roe,’ contraceptive failures carry bigger stakes

New test detects low levels of pathogenic amphiphilic endotoxins

New insights into the dynamic inner world of the human immune system

COVID-19 pandemic increased deaths and disease caused by tuberculosis

An unprecedented list of health-threatening fungi released by the WHO

Harmless group of bacteria linked with increased risk of death in patients with end-stage renal disease

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

The Black Death may have influenced the evolution of genes involved in immune responses against pathogens

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

Researchers receive £9.8m to tackle the rising challenge of non-communicable diseases in West Africa

Chinese scientists reveal a previously undefined pathway by which Mtb counteracts host immunity

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Tuberculosis News and Research

Latest Tuberculosis News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in